CSBR
Champions Oncology Inc
4.80$
+0.6%
vs. previous close
Closing price · As of: Nov 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +26.2% | +37.8% | +31.3% | +33.7% | +18.7% | +27.8% | +19.7% | +9.7% | -6.9% | +13.5% | +4.4% | |
| – | +13.8% | +11.7% | +8.8% | +35.2% | +19.2% | +26.2% | +10.2% | +25.0% | -0.4% | -3.4% | +8.8% | |
| – | +102.9% | +128.7% | +69.7% | +32.1% | +18.1% | +29.6% | +30.0% | -4.5% | -14.7% | +37.6% | -0.1% | |
| – | -13.4% | +2.4% | +2.5% | +9.0% | +22.0% | +22.9% | +30.3% | +23.2% | -17.3% | -28.5% | +33.1% | |
| – | -3.1% | -4.1% | -18.0% | +14.9% | +41.4% | -1.5% | +40.0% | +12.3% | +8.1% | -15.6% | +19.4% | |
| – | -11.4% | -2.3% | -11.8% | +13.5% | +36.0% | +12.8% | +29.3% | +15.7% | -3.9% | -14.3% | +25.1% | |
| – | – | – | – | – | -811.5% | – | +65.8% | -832.9% | – | – | -123.5% | |
| – | – | – | – | – | +1,725.6% | -90.0% | -66.2% | – | – | -3.6% | – | |
| – | – | – | – | – | -949.8% | – | +33.4% | -1,003.4% | – | – | -120.1% | |
| – | -27.6% | -79.3% | +73.7% | +212.1% | +26.2% | -42.3% | -53.3% | +94.3% | -147.1% | – | – | |
| – | – | – | – | – | -1,735.2% | – | +51.4% | -1,073.5% | – | – | -125.0% | |
| – | – | – | – | – | -186.9% | – | +42.6% | -236.7% | – | – | -92.9% |
Data as of: November 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.